NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the following investor conferences:
NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the following investor conferences: